CIBC Private Wealth Group LLC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 85 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2015. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC Private Wealth Group LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$320,000
+7.0%
43,0000.0%0.00%0.0%
Q4 2016$299,000
-15.5%
43,0000.0%0.00%0.0%
Q3 2016$354,000
+1.7%
43,0000.0%0.00%
-33.3%
Q2 2016$348,000
+59.6%
43,0000.0%0.00%
+50.0%
Q1 2016$218,000
-34.3%
43,0000.0%0.00%
-33.3%
Q4 2015$332,000
+33.9%
43,0000.0%0.00%
+50.0%
Q3 2015$248,000
-37.1%
43,0000.0%0.00%
-33.3%
Q2 2015$394,000
-24.4%
43,0000.0%0.00%
-25.0%
Q1 2015$521,00043,0000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q4 2015
NameSharesValueWeighting ↓
Ayer Capital Management, LP 5,604,015$67,865,00099.40%
Avoro Capital Advisors LLC 2,149,907$26,035,0009.99%
ACUTA CAPITAL PARTNERS, LLC 669,196$8,104,0006.83%
Perceptive Advisors 2,714,549$32,873,0002.56%
Opaleye Management Inc. 200,000$2,422,0001.12%
Broadfin Capital, LLC 1,062,419$12,866,0001.00%
QVT Financial LP 1,325,000$16,046,0000.89%
Ghost Tree Capital, LLC 400,000$4,844,0000.87%
Cormorant Asset Management, LP 424,815$5,145,0000.80%
P.A.W. CAPITAL CORP 65,000$787,0000.78%
View complete list of LION BIOTECHNOLOGIES INC shareholders